Usman Alam

[Leandro Slipczuk @CardioMDPhD]

Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies
@Usman_Alam_ @SheetalMathai @analyzeF @ToshikiKuno @juanbadimon @AllanSniderman @virani_md @DrMichaelShapir @DLBHATTMD
https://t.co/AdHZ8gIyau
@MonteHeart

[Robert Zhang MD @robertshiuzhang]

🚨📢New in @ThrombosisRese1
We found that CT RV/LV diameter ratio >1.0 is a strong predictor of low⬇️cardiac index & ⬆️mPAP in acute PE, offering a simple, real-time risk stratification tool. @SripalBangalore @CardsNYC @jameshorowitzmd
📄Read more: 🔗https://t.co/fIE1Jdfw5V

[Robert Zhang MD @robertshiuzhang]

Indexed RV volumes can miss dilation, esp at extremes of body size. In @PCVDJournal, we show that relative RV size (RV/LV volume ratio) improves detection of RV dilation & predicts outcomes🫀🏥🪦in PH. @JiwonKimMD @MMukherjeeMD @Tsay_What @CardioMDPhD
🔗https://t.co/baRhXwSXQ2

[Robert Zhang MD @robertshiuzhang]

In @ccijournal, we examine real-world outcomes of CDT vs CBT in acute PE, placing our findings in the context of the recently published #PEERLESS trial

🔗https://t.co/VYag7wXuIA

@SripalBangalore @CardsNYC @jameshorowitzmd @btaslakianMD @peter_szz @PERTConsortium

[André Zimerman @AndreZimerman]

"Does lowering LDL-C to very low levels result in long-term cognitive impairment?" 🧠🫀

I've heard this question many times.

Now we have long-term data.

A 🧵 on our new @NEJMEvidence paper: https://t.co/J8OteDNWfd

@TIMIStudyGroup @rgiugliano @DrM_ODonoghue

[Robert Zhang MD @robertshiuzhang]

🚨Excited to share our latest work looking at mitigating health disparities by improving access to CBT for vulnerable patients with acute PE
🔗https://t.co/G8Ydt7y3bi
@SripalBangalore @CRMjournal @CardsNYC @LeivaOrly @NYULangonePCCSM @grecoa3 @carlosalviar @sylvie_francine

[Robert Zhang MD @robertshiuzhang]

2/ This was subsequently validated in a separate cohort
👉https://t.co/SnFofPhYWk
@drandrewsharp @jaygirimd @grecoa3 @carlosalviar @EricSecemskyMD @sanjum @itsradu @Usman_Alam_
But does the CPES score which predicts normotensive shock, predict adverse clinical outcomes?

[Robert Zhang MD @robertshiuzhang]

📢How are you risk stratifying your pts with intermediate risk PE? Have you considered using the CPES score? ✅out our latest 📜 in @CircIntv showing that the CPES score predicts adverse outcomes in PE.
🔗https://t.co/X3bv4d3JLu
@SripalBangalore @SVRaoMD @CardsNYC
A short 🧵 ⤵️

[Robert Zhang MD @robertshiuzhang]

📢Thrilled to share our experience with mechanical thrombectomy in acute PE at a safety-net 🏥! @SripalBangalore @nyugrossman @ccijournal @ArushiSinghMD @LindsayElbaum @KelseyGrossman @CardsNYC @carlosalviar @haisummaqsood @grecoa3 @jameshorowitzmd
https://t.co/AncfcYLLKo

[Robert Zhang MD @robertshiuzhang]

Thrilled to share our review paper on the role of echo in the diagnosis/management of mechanical complications post-MI. Immense gratitude to @SamuelB316 for his mentorship and for this incredible opportunity! @saricmu @avainrib1 @nyugrossman
https://t.co/EH0vylM6pk

[Robert Zhang MD @robertshiuzhang]

Congrats Eugene Yuriditsky @CardsNYC on this excellent paper looking at the CO2 gap in patients with acute PE! @SripalBangalore @jameshorowitzmd @nyugrossman
https://t.co/4D95fDkAYy
#ACVC_ESC

[Robert Zhang MD @robertshiuzhang]

Thrilled to share our latest research letter📜, demonstrating that ICE is a reasonable alternative to TEE for percutaneous debulking of tricuspid endocarditis! @SripalBangalore @haisummaqsood
https://t.co/EQlYhN3gLr

[Orly Leiva, MD FACC @LeivaOrly]

Excited to share our new review in @RCMjournal. Cardiotox in cancer #cardioonc pts is usually assoc w/ LV dysfunx, however cancer tx can affect the RV #ThePeoplesVentricle. We review incidence and management of PH/RV dysfunction. @datsunian @manyooa
https://t.co/mddKt51EiF

[Adam J Small, MD @achd_nyc]

https://t.co/sxLLPiMuCC Thanks to @CBSMornings @NancyChenNews for including me in this important story!!

[Robert Zhang MD @robertshiuzhang]

Excited to share our network meta-analysis comparing AC, CDT & ST in acute PE!
👉CDT ⬇️mortality🪦vs AC & ST
👉AC ⬇️🩸vs CDT & ST
👉CDT⬇️ICH🧠vs ST

Grateful 🙏for the invaluable mentorship from @SripalBangalore
@nyugrossman @JACCJournals @haisummaqsood 🔗https://t.co/a33AxcSb2H

[Robert Zhang MD @robertshiuzhang]

Thrilled to share our latest case on the Treatment of Purulent Pericarditis using Intrapericardial Alteplase! @CircImaging @nyugrossman @ArushiSinghMD @KelseyGrossman @Usman_Alam_ @SripalBangalore

https://t.co/9Mod4Sapyk

[Eric H Yang, MD @datsunian]

I had a fantastic time in heralding back in person @UCLAHealth @DOM_UCLA Grand Rounds!

🙏 @IntMedAbel @uclaimchiefs for the opportunity & platform to highlight the advances & “predictions” (right or wrong) for the #cardioonc field.

#bruinhearts

https://t.co/fDtRLljW9z…
1/

[Robert Zhang MD @robertshiuzhang]

🔥Hot off the press!✅ out our new article⤵️
Outcomes With Percutaneous Debulking of Tricuspid Valve Endocarditis https://t.co/pR8hk9REz5
@SripalBangalore @LindsayElbaum @SVRaoMD @carlosalviar @nyugrossman

[Eric H Yang, MD @datsunian]

Great work from @NYULHCVRC @nyulangone @LeivaOrly & @nyugrossman @Usman_Alam_ #isaacbohart on this @SpringerHealth review of IC challenges unique to #cardioonc

As cancer survivors ⬆️, ❤️ dz should be top concern, from CVD ➡️arrhythmias ➡️ valves ➡️ HF!

https://t.co/bQt0vBTcCg

[Orly Leiva, MD FACC @LeivaOrly]

🚨New review🚨
Pt w/ cancer are at ⬆️ risk of 🫀 dz that often require intervention. Proceduralist are often hesitant to offer potentially lifesaving therapy. Here we review outcomes of IC procedures in pt w cancer! #cardioonc @datsunian @Usman_Alam_
https://t.co/aXMVOXEqnR